双极性抑郁症中的抗抑郁药:从神经递质机制到临床挑战
Simone Pardossi1, Andrea Fagiolini1, Alessandro Cuomo1
1Department of Molecular Medicine, University of Siena School of Medicine, 53100 Siena, Italy.
Actas espanolas de psiquiatria
|May 12, 2025
概括
尽管选择有限,但抗抑郁药在双极性抑郁症中存在争议. 这篇评论考察了神经递质和抗抑郁药的有效性,表明SSRI与情绪稳定剂可能为双极性抑郁症提供更安全的治疗.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 双极性障碍 (BD) 涉及躁狂和抑郁症,抑郁症显著影响生活质量.
- 目前对双极性抑郁症的治疗指南提供了有限的选择,但抗抑郁药经常被处方.
- 在BD中使用抗抑郁药是有争议的,原因是诸如躁狂诱导和症状不稳定等风险.
研究的目的:
- 在BD阶段审查神经递质机制.
- 评估抗抑郁药物治疗双极性抑郁症的疗效和安全性.
- 探索BD诊断和治疗的挑战,特别是伴随疾病.
主要方法:
- 文献综述侧重于BD中的神经递质系统 (单胺).
- 对抗抑郁药物治疗双极性抑郁症的疗效和安全性数据的分析.
- 讨论现实世界BD患者的诊断复杂性和治疗挑战.
主要成果:
- 上腺素和多巴胺都与BD的躁狂和抑郁阶段有关.
- 色素在抑郁阶段似乎缺乏,但在躁狂时不平衡.
- 选择性血清素再吸收抑制剂 (SSRI) 是有前途的,特别是与情绪稳定剂一起使用,并且通常比TCA更安全.
结论:
- 在双相抑郁症中优化抗抑郁药的使用需要了解神经递质作用和个体患者的因素.
- 识别治疗反应的预测因素,如症状严重程度和并发症,对于个性化治疗至关重要.
- 对情绪障碍谱和个性化预测因子的进一步研究可以提高双极性抑郁症的治疗结果.
相关概念视频
01:24Mania and Antimanic Drugs: Overview
106
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
106
01:18Depression: Overview
201
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
201
01:25Antidepressant Drugs: Overview
332
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
332
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
249
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
249
01:23Antidepressant Drugs: MAOIs and Other Agents
170
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
170
01:30Bipolar Disorder
41
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
41